Pfizer Inc

If you haven’t heard of Pfizer over the past couple of years, then you have probably been living off the grid. This century-old powerhouse is one of the world’s leading pharmaceutical and biotechnology companies. You might have heard of the company’s COVID-19 vaccine, but PFE is so much more. Other popular breakthrough drugs the company has developed include Viagra and Lipitor—the best-selling drug in history.

$22.92
(as of Apr 25, 7:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Pfizer Inc

Stock Price
$22.92
Ticker Symbol
PFE
Exchange
NYSE

Industry Information for Pfizer Inc

Sector
Healthcare
Industry
Drug Manufacturers - General

Company Description for Pfizer Inc

Country
USA
Full Time Employees
81,000

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Fundamentals for Pfizer Inc

Market Capitalization
$129,195,638,784
EBITDA
$23,321,999,360
Dividends per Share
$1.68
P/E Ratio
16.16
Forward P/E Ratio
7.75
Earnings per Share
$1.41
Earnings per Share Estimate Next Year
Profit Margin
12.62%
Shares Outstanding
5,671,450,112
Percent Owned by Insiders
0.06%
Percent Owned by Institutions
67.77%
52-Week High
52-Week Low

Technical Indicators for Pfizer Inc

50-Day Moving Average
200-Day Moving Average
RSI
42.77
0.72

Analyst Ratings for Pfizer Inc

Strong Buy
6
Buy
2
Hold
14
Sell
0
Strong Sell
1

News About Pfizer Inc

Apr 25, 2025, 5:30 PM EST
The stock market braces for a big week for earnings, economic news and trade war issues. See more.
Apr 25, 2025, 7:06 AM EST
Pfizer's PFE non-COVID operational revenues improved in 2024, driven by its key in-line products like Vyndaqel, Padcev and Eliquis, new launches and newly acquired products from Seagen. See more.
Apr 25, 2025, 1:00 AM EST
Earnings season is now in full swing, with a number of key companies due to report in the coming week, including four of the Magnificent 7 tech giants in focus. See more.
Apr 24, 2025, 4:05 PM EST
Health care stocks were higher late Thursday afternoon, with the NYSE Health Care Index rising 1.3% See more.